A novel way to speed the testing of cancer drugs and quickly separate winners from duds has yielded its first big result: an experimental medicine that shows promise against a hard-to-treat form of breast cancer.
Dec 13, 2013
5 / 5 (2) | 0
Researchers at Fox Chase Cancer Center are enrolling newly diagnosed breast cancer patients into a clinical trial of the promising drug reparixin, which targets tumors' ability to self-renew. The study, being presented at ...
Dec 12, 2013
5 / 5 (1) | 0